Goldman Sachs Files 424B2 Prospectus for New Securities Offering

TL;DR

**GS just filed a prospectus, probably gearing up for a new offering.**

AI Summary

Goldman Sachs Group Inc. filed a 424B2 prospectus on March 24, 2026, related to a previous registration statement (File No. 333-284538). This filing is a standard update for offering securities, indicating that Goldman Sachs is likely preparing to issue new financial products. For investors, this matters because new offerings can dilute existing shares or signal the company's capital-raising strategies, potentially impacting future earnings and stock value.

Why It Matters

This filing indicates Goldman Sachs is updating its ability to offer new securities, which could impact the supply and demand dynamics of its stock and other financial products.

Risk Assessment

Risk Level: low — This is a routine regulatory filing for a large financial institution and does not inherently signal immediate high risk, though future offerings could carry risk.

Analyst Insight

Investors should monitor Goldman Sachs for subsequent announcements regarding specific security offerings, as this 424B2 filing is a preparatory step for such actions. Evaluate the terms of any new offerings for potential impact on existing share value.

Key Numbers

• 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed by Goldman Sachs)
• 333-284538 — File No. (The registration statement number this 424B2 prospectus supplements)

Key Players & Entities

• GOLDMAN SACHS GROUP INC (company) — Filer of the 424B2 prospectus
• 0000886982 (company) — CIK of Goldman Sachs Group Inc.
• 333-284538 (dollar_amount) — File number for the related registration statement
• 2026-03-24 (dollar_amount) — Filing and acceptance date of the 424B2

FAQ

Key Financial Figures

• $10,000,000 — Registration Statement No. 333-284538 $10,000,000 The Goldman Sachs Group, Inc. Calla
• $122,500 — ,000 Underwriting discount 1.225% $122,500 Proceeds, before expenses, to The Gol
• $9,877,500 — e Goldman Sachs Group, Inc. 98.775% $9,877,500 The initial price to public set forth
• $1,000 — xed rate notes (notes) Denominations: $1,000 and integral multiples of $1,000 in exc
• $5,000,000 — nt of Notes Goldman Sachs & Co. LLC $5,000,000 InspereX LLC $5,000,000 Total $
• $15,000 — ther underwriter, will be approximately $15,000. We will deliver the notes against pa

Filing Documents

• gs-20260324.htm (424B2) — 111KB
• gs_exfilingfees.htm (EX-FILING FEES) — 5KB
• img262706491_0.jpg (GRAPHIC) — 6KB
• img262706491_1.gif (GRAPHIC) — 20KB
• 0001193125-26-120965.txt ( ) — 246KB
• gs_exfilingfees_htm.xml (XML) — 3KB

From the Filing

424B2 Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-284538 $10,000,000 The Goldman Sachs Group, Inc. Callable Fixed Rate Notes due 2031 We will pay you interest on your notes at a rate of 4.55% per annum from and including the original issue date (March 24, 2026) to but excluding the stated maturity date (March 7, 2031). Interest will be paid on each interest payment date (March 24 of each year and the stated maturity date). The first such payment will be made on the first interest payment date (March 24, 2027). In addition, we may redeem the notes at our option, in whole but not in part, on each redemption date (each March 24, June 24, September 24 and December 24 on or after March 24, 2027), upon at least five business days’ prior notice, at a redemption price equal to 100% of the outstanding principal amount plus accrued and unpaid interest to but excluding the redemption date. Per Note Total Initial price to public 100% $10,000,000 Underwriting discount 1.225% $122,500 Proceeds, before expenses, to The Goldman Sachs Group, Inc. 98.775% $9,877,500 The initial price to public set forth above does not include accrued interest, if any. Interest on the notes will accrue from the original issue date and must be paid by the purchaser if the notes are delivered after the original issue date. In addition to offers and sales at the initial price to public, the underwriters may offer the notes from time to time for sale in one or more transactions at market prices prevailing at the time of sale, at prices related to market prices or at negotiated prices. The return (whether positive or negative) on your investment in notes will depend in part on the issue price you pay for such notes. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. The notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank. Goldman Sachs may use this prospectus in the initial sale of the notes. In addition, Goldman Sachs & Co. LLC or any other affiliate of Goldman Sachs may use this prospectus in a market-making transaction in the notes after their initial sale. Unless Goldman Sachs or its agent informs the purchaser otherwise in the confirmation of sale, this prospectus is being used in a market-making transaction. Goldman Sachs & Co. LLC InspereX LLC Pricing Supplement No. 1,680 dated March 20, 2026. About Your Prospectus The notes are part of the Medium-Term Notes, Series N program of The Goldman Sachs Group, Inc. This prospectus includes this pricing supplement and the accompanying documents listed below. This pricing supplement constitutes a supplement to the documents listed below and should be read in conjunction with such documents: • Prospectus supplement dated February 14, 2025 • Prospectus dated February 14, 2025 The information in this pricing supplement supersedes any conflicting information in the documents listed above. In addition, some of the terms or features described in the listed documents may not apply to your notes. PS- 2 SPECIFIC TERMS OF THE NOTES Please note that in this section entitled “Specific Terms of the Notes”, references to “The Goldman Sachs Group, Inc.”, “we”, “our” and “us” mean only The Goldman Sachs Group, Inc. and do not include any of its subsidiaries or affiliates. Also, in this section, references to “holders” mean The Depository Trust Company (DTC) or its nominee and not indirect owners who own beneficial interests in notes through participants in DTC. Please review the special considerations that apply to indirect owners in the accompanying prospectus, under “Legal Ownership and Book-Entry Issuance”. This pricing supplement no. 1,680 dated March 20, 2026 (pricing supplement) and the accompanying prospectus dated February 14, 2025 (accompanying prospectus), relating to the notes, should be read together. Because the notes are part of a series of our debt securities called Medium-Term Notes, Series N, this pricing supplement and the accompanying prospectus should also be read with the accompanying prospectus supplement, dated February 14, 2025 (accompanying prospectus supplement). Terms used but not defined in this pricing supplement have the meanings given them in the accompanying prospectus or accompanying prospectus supplement, unless the context requires otherwise. The notes are part of a separate series of our debt securities under our Medium-Term Notes, Series N program governed by our Senior Debt Indenture, dated as of July 16, 2008, as amended, between us and The Bank of New Yo

View Full Filing

View this 424B2 filing on SEC EDGAR